Cargando…

Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis

BACKGROUND: We performed a single-institution retrospective study to evaluate the efficacy and toxicities of combination therapy with docetaxel and S-1 in patients with advanced or recurrent gastric cancer. METHODS: Eighty-six patients with advanced or recurrent gastric cancer were enrolled. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanabe, Kazuaki, Suzuki, Takahisa, Tokumoto, Noriaki, Yamamoto, Hideki, Yoshida, Kazuhiro, Ohdan, Hideki
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885397/ https://www.ncbi.nlm.nih.gov/pubmed/20482840 http://dx.doi.org/10.1186/1477-7819-8-40

Ejemplares similares

Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis
por: Tanimine, Naoki, et al.
Publicado: (2012)

Triple-Tube-Ostomy: A Novel Technique for the Surgical Treatment of Iatrogenic Duodenal Perforation
por: Fujikuni, Nobuaki, et al.
Publicado: (2011)

Thoracoscopic-assisted repair of a bochdalek hernia in an adult: a case report
por: Tokumoto, Noriaki, et al.
Publicado: (2010)

A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report
por: Yanagawa, Senichiro, et al.
Publicado: (2014)

Idiopathic Granulomatous Gastritis Resembling a Gastrointestinal Stromal Tumor
por: Niitsu, Hiroaki, et al.
Publicado: (2012)

Perioperative management of polycythemia vera with advanced gastric cancer: A case report
por: Mochizuki, Tetsuya, et al.
Publicado: (2019)

The long-term survival of stage IV gastric cancer patients with conversion therapy
por: Yamaguchi, Kazuya, et al.
Publicado: (2017)

Fasting Enhances TRAIL-Mediated Liver Natural Killer Cell Activity via HSP70 Upregulation
por: Dang, Vu T. A., et al.
Publicado: (2014)

Distal Gastrectomy for Symptomatic Stage IV Gastric Cancer Contributes to Prognosis with Acceptable Safety Compared to Gastrojejunostomy
por: Fujikuni, Nobuaki, et al.
Publicado: (2022)

Stimulation of natural killer cells with rhCD137 ligand enhances tumor-targeting antibody efficacy in gastric cancer
por: Misumi, Toshihiro, et al.
Publicado: (2018)

Revascularization for cavernous transformation radical lymphadenectomy in the treatment of gastric cancer: A case report
por: Yoshinaka, Hisaaki, et al.
Publicado: (2018)

Successful management of multiple liver metastasis from gastric cancer with second conversion surgery: A case report
por: Sato, Saki, et al.
Publicado: (2023)

Initial experiences of robotic versus conventional laparoscopic surgery for colorectal cancer, focusing on short-term outcomes: a matched case-control study
por: Sawada, Hiroyuki, et al.
Publicado: (2015)

Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion
por: Fujikuni, Nobuaki, et al.
Publicado: (2014)

Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study
por: Li, Jinyu, et al.
Publicado: (2015)

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Hepatic resection using intraoperative ultrasound and near-infrared imaging with indocyanine green fluorescence detects hepatic metastases from gastric cancer: A case report
por: Tadokoro, Takeshi, et al.
Publicado: (2022)

The involvement of circulating CD69(+) CD56(bright) natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
por: Chikuie, Emi, et al.
Publicado: (2023)

Successful robotic proximal gastrectomy with side overlap esophagogastrostomy following preoperative chemotherapy: A case report
por: Tanabe, Kazuaki, et al.
Publicado: (2022)

Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2013)

Laparoscopic proximal gastrectomy with hinged double flap method using knotless barbed absorbable sutures: A case series
por: Saeki, Yoshihiro, et al.
Publicado: (2018)

Iatrogenic hepatic granuloma (suspected liver metastatic lesion on imaging) caused by liver retraction during laparoscopic gastrectomy: A case report
por: Bekki, Tomoaki, et al.
Publicado: (2020)

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
por: Koizumi, Wasaburo, et al.
Publicado: (2013)

Percutaneous Trans-Esophageal Gastrostomy for Oral Intake in a Case of Anastomotic Obstruction following Total Gastrectomy
por: Shishida, Masayuki, et al.
Publicado: (2023)

A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
por: Ni, Lu, et al.
Publicado: (2021)

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
por: Lin, Haimin, et al.
Publicado: (2019)

Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
por: YUAN, MEIQIN, et al.
Publicado: (2014)

Laparoscopic extra-abdominal suturing technique for the repair of Larrey’s diaphragmatic hernia using the port closure needle (Endo Close(®)): A case report
por: Yamamoto, Yuji, et al.
Publicado: (2016)

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
por: Wang, Jinwan, et al.
Publicado: (2015)

Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer
por: Wei, J, et al.
Publicado: (2014)

Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population
por: Nakamura, Koki, et al.
Publicado: (2020)

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study
por: Ardavanis, A, et al.
Publicado: (2005)

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison
por: Redana, Stefania, et al.
Publicado: (2010)

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
por: Hayashi, Tsutomu, et al.
Publicado: (2020)

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer
por: Vasey, P A, et al.
Publicado: (2006)

Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer
por: RINO, YASUSHI, et al.
Publicado: (2013)

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
por: Vasey, P A, et al.
Publicado: (2001)

SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation
por: Bin, Yehong, et al.
Publicado: (2022)

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
por: Kano, Masayuki, et al.
Publicado: (2019)

Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
por: AOKI, TAKUYA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s7e7eaqu1mipcnqed40kibv8st